Scott A. Byrd

Scott A. Byrd is a declared insider of Cadence Pharmaceuticals Inc, with filings sourced from SEC (Form 4). In total, 9 filings cover trades dated from 10 May 2011 to 19 March 2014.

Market trades split into 1 purchase (€10k) and 3 sales (€496k). On balance, insiders were net sellers of €486k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 4 option exercises.

The record was last updated on 21 March 2014 with a transaction (€20k) in Cadence Pharmaceuticals Inc. The most recent open-market purchase was published on 11 May 2011, 5,644 days ago. Typically, a trade is published a median of 3 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.